Our study provided strong evidence that miR-135a was expressed at low levels in lung cancer cells and tissues, and it inhibited lung cancer cell growth, invasion and metastasis by suppressing the expression of RAB1B and multiple key components of the RAS pathway (Figure 5). This evidence concerns the gene RAB1B and lung cancer.